Original Source(s)
Related Content
GLP-1 RAs May Ease Psoriasis, PsA Data Limited
Published evidence linked liraglutide and semaglutide to improvements in psoriasis severity, inflammatory markers, and metabolic outcomes, while evidence in psoriatic arthritis remained sparse.
June 27, 2026
-
4 min
Dupilumab Gains Pediatric CSU Approval
Targets type 2 inflammation in a population with limited treatment options
April 24, 2026
-
2 min
FDA Approves Less Frequent Lebrikizumab Dosing
Approval adds an every-8-week maintenance option for eligible patients with moderate-to-severe atopic dermatitis.
June 10, 2026
-
2 min